-
1 Comment
Quest Diagnostics Incorporated is currently in a long term uptrend where the price is trading 7.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.
Quest Diagnostics Incorporated's total revenue rose by 55.9% to $3B since the same quarter in the previous year.
Its net income has increased by 128.9% to $579M since the same quarter in the previous year.
Finally, its free cash flow grew by 115.3% to $379M since the same quarter in the previous year.
Based on the above factors, Quest Diagnostics Incorporated gets an overall score of 5/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | US74834L1008 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Market Cap | 16B |
---|---|
PE Ratio | 21.41 |
Target Price | 157.67 |
Dividend Yield | 2.0% |
Beta | 0.78 |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for QDI.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025